Biomolecular Mechanisms of Calvarial Bone Induction: Immature versus Mature Dura Mater

The ability of newborns and immature animals to reossify calvarial defects has been well described. This capacity is generally lost in children greater than 2 years of age and in mature animals. The dura mater has been implicated as a regulator of calvarial reossification. To date, however, few studies have attempted to identify biomolecular differences in the dura mater that enable immature, but not mature, dura to induce osteogenesis. The purpose of these studies was to analyze metabolic characteristics, protein/gene expression, and capacity to form mineralized bone nodules of cells derived from immature and mature dura mater. Transforming growth factor beta‐1, basic fibroblast growth factor, collagen type I&agr;I, osteocalcin, and alkaline phosphatase are critical growth factors and extracellular matrix proteins essential for successful osteogenesis. In this study, we have characterized the proliferation rates of immature (6‐day‐old rats, n = 40) and mature (adult rats, n = 10) dura cell cultures. In addition, we analyzed the expression of transforming growth factor beta‐1, basic fibroblast growth factor‐2, proliferating cell nuclear antigen, and alkaline phosphatase. Our in vitro findings were corroborated with Northern blot analysis of mRNA expression in total cellular RNA isolated from snap‐frozen age‐matched dural tissues (6‐day‐old rats, n = 60; adult rats, n = 10). Finally, the capacity of cultured dural cells to form mineralized bone nodules was assessed. We demonstrated that immature dural cells proliferate significantly faster and produce significantly more proliferating cell nuclear antigen than mature dural cells (p < 0.01). Additionally, immature dural cells produce significantly greater amounts of transforming growth factor beta‐1, basic fibroblast growth factor‐2, and alkaline phosphatase (p < 0.01). Furthermore, Northern blot analysis of RNA isolated from immature and mature dural tissues demonstrated a greater than 9‐fold, 8‐fold, and 21‐fold increase in transforming growth factor beta‐1, osteocalcin, and collagen I&agr;I gene expression, respectively, in immature as compared with mature dura mater. Finally, in keeping with their in vivo phenotype, immature dural cells formed large calcified bone nodules in vitro, whereas mature dural cells failed to form bone nodules even with extended culture. These studies suggest that differential expression of growth factors and extracellular matrix molecules may be a critical difference between the osteoinductive capacity of immature and mature dura mater. Finally, we believe that the biomolecular bone‐ and matrix‐inducing phenotype of immature dura mater regulates the ability of young children and immature animals to heal calvarial defects. (Plast. Reconstr. Surg. 105: 1382, 2000.)

[1]  M. Longaker,et al.  Regional differentiation of rat cranial suture-derived dural cells is dependent on association with fusing and patent cranial sutures. , 1999, Plastic and reconstructive surgery.

[2]  M. Longaker,et al.  Basic fibroblast growth factor and transforming growth factor beta-1 expression in the developing dura mater correlates with calvarial bone formation. , 1999, Plastic and reconstructive surgery.

[3]  J. McCarthy,et al.  Rat mandibular distraction osteogenesis: II. Molecular analysis of transforming growth factor beta-1 and osteocalcin gene expression. , 1999, Plastic and reconstructive surgery.

[4]  Y. Kato,et al.  Local Application of Basic Fibroblast Growth Factor Minipellet Induces the Healing of Segmental Bony Defects in Rabbits , 1998, Calcified Tissue International.

[5]  G. Karsenty,et al.  Genetic control of cell differentiation in the skeleton. , 1998, Current opinion in cell biology.

[6]  T. Miki,et al.  [Biochemical markers of bone metabolism]. , 1998, Nihon rinsho. Japanese journal of clinical medicine.

[7]  R H Christenson,et al.  Biochemical markers of bone metabolism: an overview. , 1997, Clinical biochemistry.

[8]  S. Glück,et al.  Evaluation of three rapid RNA extraction reagents: relevance for use in RT-PCR's and measurement of low level gene expression in clinical samples. , 1997, Cellular and molecular biology.

[9]  Jack C. Yu,et al.  Regional Differences of Dura Osteoinduction: Squamous Dura Induces Osteogenesis, Sutural Dura Induces Chondrogenesis and Osteogenesis , 1997, Plastic and reconstructive surgery.

[10]  G. Karsenty,et al.  Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.

[11]  T. Nakamura,et al.  Stimulation of endosteal bone formation by local intraosseous application of basic fibroblast growth factor in rats. , 1997, Revue du rhumatisme.

[12]  Douglas C. Miller,et al.  Histopathologic and Biochemical Changes in the Muscles Affected by Distraction Osteogenesis of the Mandible , 1997, Plastic and reconstructive surgery.

[13]  A. Tencer,et al.  TGF-beta 1 forms functionally normal bone in a segmental sheep tibial diaphyseal defect. , 1996, The Journal of otolaryngology.

[14]  A. Caplan,et al.  Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF‐β1 or PDGF‐BB as assayed in vivo and in vitro , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  J. Zerwekh,et al.  The importance of the dura in craniofacial surgery. , 1996, Plastic and reconstructive surgery.

[16]  M. Crescenzi,et al.  Adenovirus Infection Induces Reentry into the Cell Cycle of Terminally Differentiated Skeletal Muscle Cells a , 1995, Annals of the New York Academy of Sciences.

[17]  M. Crescenzi,et al.  Mitotic cycle reactivation in terminally differentiated cells by adenovirus infection , 1995, Journal of cellular physiology.

[18]  S. Nomura,et al.  Localization of the mRNA for bone matrix proteins during fracture healing as determined by in situ hybridization , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  E. Ogata,et al.  Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. , 1994, Endocrinology.

[20]  U. Novak,et al.  Cytokine modulation of plasminogen activator inhibitor-1 (PAI-1) production by human articular cartilage and chondrocytes. Down-regulation by tumor necrosis factor alpha and up-regulation by transforming growth factor-B basic fibroblast growth factor. , 1994, Biochimica et biophysica acta.

[21]  L. Bonewald,et al.  Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long‐term cultures of fetal rat calvarial osteoblasts , 1994 .

[22]  G. Rodan,et al.  Activity of the rat osteocalcin basal promoter in osteoblastic cells is dependent upon homeodomain and CP1 binding motifs. , 1994, Molecular endocrinology.

[23]  Jonathan A. Cooper,et al.  A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase , 1994, Molecular and cellular biology.

[24]  J. McCarthy,et al.  The Role of the Dura in Cranial Bone Regeneration in the Immature Animal , 1993, Plastic and reconstructive surgery.

[25]  M. Berridge,et al.  Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. , 1993, Archives of biochemistry and biophysics.

[26]  E. Vuorio,et al.  Gene expression during bone repair. , 1993, Clinical orthopaedics and related research.

[27]  W. Kueng,et al.  Quantification of cells cultured on 96-well plates. , 1989, Analytical Biochemistry.

[28]  B. Olwin,et al.  Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture , 1988, The Journal of cell biology.

[29]  J. Pfeilschifter,et al.  Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures. , 1988, The Journal of clinical investigation.

[30]  D. Gospodarowicz,et al.  Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor beta. , 1988, Endocrinology.

[31]  G. Spizz,et al.  Decrease in transforming growth factor-beta binding and action during differentiation in muscle cells. , 1988, The Journal of biological chemistry.

[32]  R. Bravo,et al.  Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites , 1987, The Journal of cell biology.

[33]  J B Lian,et al.  Expression of differentiated function by mineralizing cultures of chicken osteoblasts. , 1987, Developmental biology.

[34]  M. Sporn,et al.  Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro , 1987, The Journal of cell biology.

[35]  E. Canalis,et al.  Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. , 1987, The Journal of biological chemistry.

[36]  E. Vuorio,et al.  Differential expression of fibrillar collagen genes during callus formation. , 1987, Biochemical and biophysical research communications.

[37]  J. Massagué,et al.  Human platelet-derived transforming growth factor-beta stimulates parameters of bone growth in fetal rat calvariae. , 1986, Endocrinology.

[38]  G. Rodeheaver,et al.  Skull growth after coronal suturectomy, periostectomy, and dural transection. , 1982, Journal of neurosurgery.

[39]  J. McCarthy,et al.  A Study of Regeneration in Parietal Bone Defects in Rabbits , 1981, Plastic and reconstructive surgery.

[40]  V. Kokich,et al.  Calvarial and sutural re-development following craniectomy in the neonatal rabbit. , 1979, Journal of anatomy.

[41]  J. Hanson,et al.  Subtotal neonatal calvariectomy for severe craniosynostosis. , 1977, The Journal of pediatrics.

[42]  A. Krasinskas,et al.  Properties of coralline hydroxyapatite and expanded polytetrafluoroethylene membrane in the immature craniofacial skeleton. , 1999, Plastic and reconstructive surgery.

[43]  M. Longaker,et al.  Hypoxia regulates VEGF expression and cellular proliferation by osteoblasts in vitro. , 1999, Plastic and reconstructive surgery.

[44]  F. Melsen,et al.  Transforming growth factor-beta enhances fracture healing in rabbit tibiae. , 1993, Acta orthopaedica Scandinavica.

[45]  E. Amento,et al.  TGF-beta 1 induces bone closure of skull defects: temporal dynamics of bone formation in defects exposed to rhTGF-beta 1. , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[46]  K. Kato,et al.  In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. , 1993, Growth factors.

[47]  P. Fottrell,et al.  Osteocalcin: diagnostic methods and clinical applications. , 1991, Critical reviews in clinical laboratory sciences.

[48]  J. Wergedal,et al.  Growth factor-induced proliferation of osteoblasts measured by bromodeoxyuridine immunocytochemistry. , 1991, Growth factors.

[49]  V. Kokich,et al.  Redevelopment of the calvaria after partial craniectomy in growing rabbits: the effect of altering dural continuity. , 1981, Acta anatomica.

[50]  K. Sirola Regeneration of defects in the calvaria. An experimental study. , 1960, Annales medicinae experimentalis et biologiae Fenniae.